134 related articles for article (PubMed ID: 22154724)
1. Favorable effects of alemtuzumab on allospecific regulatory T-cell generation.
Levitsky J; Leventhal JR; Miller J; Huang X; Chen L; Chandrasekaran D; Tambur AR; Mathew JM
Hum Immunol; 2012 Feb; 73(2):141-9. PubMed ID: 22154724
[TBL] [Abstract][Full Text] [Related]
2. Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction.
Levitsky J; Gallon L; Miller J; Tambur AR; Leventhal J; Flaa C; Huang X; Sarraj B; Wang E; Mathew JM
Transplantation; 2011 Jan; 91(2):199-206. PubMed ID: 21239962
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of belatacept on allospecific regulatory T-cell generation in humans.
Levitsky J; Miller J; Huang X; Chandrasekaran D; Chen L; Mathew JM
Transplantation; 2013 Oct; 96(8):689-96. PubMed ID: 23883971
[TBL] [Abstract][Full Text] [Related]
4. The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation.
Levitsky J; Miller J; Leventhal J; Huang X; Flaa C; Wang E; Tambur A; Burt RK; Gallon L; Mathew JM
Transplantation; 2009 Dec; 88(11):1303-11. PubMed ID: 19996930
[TBL] [Abstract][Full Text] [Related]
5. Requirement of cognate CD4+ T-cell recognition for the regulation of allospecific CTL by human CD4+ CD127- CD25+ FOXP3+ cells generated in MLR.
Yu Y; Miller J; Leventhal JR; Tambur AR; Chandrasekaran D; Levitsky J; Luo X; Mathew JM
PLoS One; 2011; 6(7):e22450. PubMed ID: 21799858
[TBL] [Abstract][Full Text] [Related]
6. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
[TBL] [Abstract][Full Text] [Related]
7. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM
Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982
[TBL] [Abstract][Full Text] [Related]
8. Immunoregulatory Effects of Everolimus on In Vitro Alloimmune Responses.
Levitsky J; Miller J; Huang X; Gallon L; Leventhal JR; Mathew JM
PLoS One; 2016; 11(6):e0156535. PubMed ID: 27275747
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
[TBL] [Abstract][Full Text] [Related]
10. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.
Schlossberger V; Schober L; Rehnitz J; Schaier M; Zeier M; Meuer S; Schmitt E; Toth B; Strowitzki T; Steinborn A
Hum Reprod; 2013 Nov; 28(11):3062-73. PubMed ID: 23925397
[TBL] [Abstract][Full Text] [Related]
11. Siplizumab selectively depletes effector memory T cells and promotes a relative expansion of alloreactive regulatory T cells in vitro.
Podestà MA; Binder C; Sellberg F; DeWolf S; Shonts B; Ho SH; Obradovic A; Waffarn E; Danzl N; Berglund D; Sykes M
Am J Transplant; 2020 Jan; 20(1):88-100. PubMed ID: 31319439
[TBL] [Abstract][Full Text] [Related]
12. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
[TBL] [Abstract][Full Text] [Related]
13. A modified flow cytometry method for objective estimation of human CD4
Petsiou A; Paschou SA; Vartholomatos G; Chatzigianni K; Kolaitis N; Giotaki E; Bondinas GP; Moustakas AK; Karamoutsios A; Zervou E; Tigas S; Tsatsoulis A; Papadopoulos GK
Cytometry B Clin Cytom; 2020 May; 98(3):259-269. PubMed ID: 31571372
[TBL] [Abstract][Full Text] [Related]
14. Impact of alemtuzumab treatment on the survival and function of human regulatory T cells in vitro.
Havari E; Turner MJ; Campos-Rivera J; Shankara S; Nguyen TH; Roberts B; Siders W; Kaplan JM
Immunology; 2014 Jan; 141(1):123-31. PubMed ID: 24116901
[TBL] [Abstract][Full Text] [Related]
15. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.
Fourtounas C; Dousdampanis P; Sakellaraki P; Rodi M; Georgakopoulos T; Vlachojannis JG; Mouzaki A
Am J Nephrol; 2010; 32(1):1-9. PubMed ID: 20484893
[TBL] [Abstract][Full Text] [Related]
16. Generation of induced regulatory T cells from primary human naïve and memory T cells.
Ellis GI; Reneer MC; Vélez-Ortega AC; McCool A; Martí F
J Vis Exp; 2012 Apr; (62):. PubMed ID: 22525890
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of allogeneic cytotoxic T cell (CD8
Kang N; Toyofuku WM; Yang X; Scott MD
Acta Biomater; 2017 Jul; 57():146-155. PubMed ID: 28442414
[TBL] [Abstract][Full Text] [Related]
18. Reduced frequency and functional defects of CD4
Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
[TBL] [Abstract][Full Text] [Related]
19. Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media.
Teng L; Liu L; Su Y; Yuan X; Li J; Fu Q; Chen S; Wang C
J Surg Res; 2011 Dec; 171(2):797-806. PubMed ID: 20538297
[TBL] [Abstract][Full Text] [Related]
20. Ethylenecarbodiimide-coupled allogeneic antigen presenting cells induce human CD4+ regulatory T cells.
Albert MH; Yu XZ; Magg T
Clin Immunol; 2008 Dec; 129(3):381-93. PubMed ID: 18819845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
